ImmunoGen, Inc.

ImmunoGen, Inc. is a leading pharmaceutical manufacturing company dedicated to developing and delivering innovative therapies. ImmunoGen, Inc. is now part of AbbVie, a global biopharmaceutical company committed to creating medicines and solutions that prioritize impact for patients, communities, and the world. AbbVie's focus lies in addressing complex health issues and enhancing lives through its core therapeutic areas, including immunology, oncology, neuroscience, eye care, aesthetics, and other areas of unmet need.

ImmunoGen, Inc. is located at 1 N Waukegan Rd, North Chicago, Illinois 60064, US. With a strong commitment to research and development, ImmunoGen, Inc. and AbbVie continue to push the boundaries of medical science to improve patient outcomes and address unmet medical needs. ImmunoGen, Inc. and AbbVie are dedicated to making a meaningful difference in the lives of patients worldwide through groundbreaking treatments and a patient-centric approach.

At ImmunoGen, Inc., the mission is to interrupt the progress of cancer, ensuring that it doesn't interrupt the lives of patients. We invite the manager of ImmunoGen, Inc. to create a customized and exclusive company showcase and product listing on our platform to further highlight ImmunoGen, Inc.'s contributions to the pharmaceutical industry.